Dear Colleagues,
The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.
If you have a resource to include in our next issue, please send to Vanetta Thomas at [email protected]. Previous issues are available on the CAMI Health website.
Best,
IMPT Secretariat Staff
|
|
Just Released
We are excited to share the following publication, which was presented by Erin Schelar at the recent ISSTDR World STI & HIV Congress: Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Schelar, E., Polis, C.B., Essam, T., Looker, K.J., Bruni, L., Chrisman, C., and Manning, J. (2015). Contraception.
We would also like thank those members of the IMPT Network of Experts and working groups who contributed to the development of this manuscript!
|
Upcoming Events
IMPT members will be presenting at several upcoming events. We encourage you to attend their sessions if you plan to attend the following conferences:
|
Journal Articles
A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models. Boyapalle, S., Xu, W., Raulji, P., Mohapatra, S., and Mohapatra, S.S. (2015, September 25). PLOS ONE.
Age-disparate partnerships and risk of HIV-1 acquisition among South African women participating in the VOICE trial. Balkus, J., Nair, G., Montgomery, E., Mishra, A., Palanee, T., Ramjee, G., ...Marrazzo, J. (2015). Journal of Acquired Immune Deficiency Syndromes.
Effect of depot medoxyprogesterone acetate on immune functions and inflammatory markers of HIV-infected women. Weinberg A1, Park JG, Bosch R, Cho A, Livingston E, Aweeka F, Cramer Y, Watts DH, Luque AE, Cohn SE. (2015, September 18). Journal of Acquired Immune Deficiency Syndromes.
Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota. Nunn, K.L., Wang, Y., Harit, D., Humphrys, M.S., Ma, B., Cone, R., Ravel, J., and Lai, S.K. (2015, October 6). mBio, 6(5).
Hormonal contraception, pregnancy, breastfeeding and risk of HIV disease progression among Zambian women. Wall, K.M., Kilembe, W., Haddad, L., Vwalika, B., Lakhi, S., Htee, N.K., ... Allen, S. (2015, September 12). Journal of Acquired Immune Deficiency Syndromes.
Incorporating acute HIV screening into routine HIV testing at sexually transmitted infection clinics and HIV testing and counseling centers in Lilongwe, Malawi. Rutstein, Sarah, Pettifor, Audrey E., Phiri, S., Kamanga, G., Hoffman, I.P.A., Hosseinipour, M.C., ...Miller, W.C. (2015, September 29). Journal of Acquired Immune Deficiency Syndromes. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Schelar, E., Polis, C.B., Essam, T., Looker, K.J., Bruni, L., Chrisman, C., and Manning, J. (2015). Contraception. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. Kovarova, M., Council, O., Date, A., Long, J., Nochii, T., Belshan, M., ... Garcia, J. (2015). PLoS Pathog PLOS Pathogens.
The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: Important targets for intervention. Loeliger, K.B., Marcus, R., Wichersham, J.A., Pillai, V., Kamarulzaman, A., and Altice, F. (2016, February). Addictive Behaviors, 53, 31-39.
|
|
|
|
|
